Literature DB >> 46673

5-S-cysteinyldopa in the plasma of melanoma patients and the renal clearance of this amino acid.

G Agrup, T Andersson, B Falck, K Persson, H Rorsman, A M Rosengren, E Rosengren.   

Abstract

5-S-cysteinyldopa has been demonstrated in the plasma of two patients with metastases of malignant melanoma and a high excretion rate of 5-S-cysteinyldopa in the urine. In one patient the plasma clearance of 5-S-cysteinyl dopa was 30 ml/min and in the other 69 ml/min. These clearance values were 43 and 45%, respectively, of the creatinine clearance in the two patients.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 46673

Source DB:  PubMed          Journal:  Acta Derm Venereol        ISSN: 0001-5555            Impact factor:   4.437


  3 in total

1.  5-S-Cysteinyldopa in ganglion stellatum.

Authors:  C Fehling; C Hansson; J Poulsen; H Rorsman; E Rosengren
Journal:  J Neural Transm       Date:  1981       Impact factor: 3.575

2.  Cysteinyldopa isomers and dopa in lesions and urine of Japanese patients with malignant melanoma.

Authors:  T Morishima; F Tatsumi; E Fukada; M Saito; M Fujita; N Nagashima; S Hanawa
Journal:  Arch Dermatol Res       Date:  1983       Impact factor: 3.017

Review 3.  Roles of catechol neurochemistry in autonomic function testing.

Authors:  David S Goldstein; William P Cheshire
Journal:  Clin Auton Res       Date:  2018-04-28       Impact factor: 4.435

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.